Guy Young

67PUBLICATIONS
127CO-AUTHORS
Gene and molecular therapyAllergyMedical infection agents (incl. prions)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Cancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (67)

|Oct 16, 2026
Cases of High-Titer Inhibitor Formation After AAV Gene Therapy for Hemophilia A.

|Oct 12, 2026
Successful Use of Sutimlimab in two Pediatric Patients With Refractory Cold Antibody-Mediated Autoimmune Hemolytic Anemia.

|Jul 24, 2026
T2* Magnetic Resonance Imaging Uncovers Hemosiderin Burden in Pediatric Hemophilia: A Call for Sensitive Imaging Biomarkers.

|Jul 17, 2026
Denecimig (Mim8) prophylaxis once every 2 weeks for hemophilia A with or without inhibitors: 26-week results from FRONTIER4.

|Jun 24, 2026
Concizumab in patients with hemophilia A or B without inhibitors: 56-week cutoff results of the phase 3 explorer8 study.

|Jun 08, 2026
Advances in Hemophilia: From Joint Health to FVIII Guidelines and the Clinical Integration of Rebalancing Agents.

Pageof 12

Frequent Collaborators

9 joint publications

Johnny N Mahlangu

8 joint publications

Steven W Pipe

7 joint publications

Flora Peyvandi

6 joint publications

Víctor Jiménez-Yuste